Category Archives: Cancer Research

Cancer Research, News

Watch that Powder, Talc use May Cause Uterine Cancer

Talcum Powder Linked to Uterine Cancer
Talcum Powder Linked to Uterine Cancer

Experts have warned about the use of talcum powder for years, but these claims have been a source of controversy. Researchers have recently put that controversy to rest by publishing the results of a study linking talcum powder to uterine cancer.

Researchers at Brigham and Women’s Hospital found that using talcum powder in the genital area can lead to a higher risk of ovarian cancer in women. In fact, this cancer risk was shown to be about one-third higher in those who use talcum powder. Scientists who participated in this study are calling for manufacturers to place labels on talcum powder products so women who use them are informed of these risks. Talcum powder is believed to raise the risk of ovarian cancer if it gets into the vagina and reaches the upper genital tract.

This study was published shortly after a jury ordered manufacturer Johnson & Johnson to pay the family of a woman who died of uterine cancer $72 million. The family claims that the woman’s use of Johnson & Johnson’s talcum powder products led to her developing this deadly form of cancer.

The Brigham and Women’s Hospital study provides further evidence that there is a link between the use of talcum powder and an increased risk of ovarian cancer. While scientists state that more research is needed, many caution against using this type of powder, especially in the genital area.

Those who are interested in learning more about non-toxic treatments for uterine cancer should contact Issels®. We offer immunotherapy and other types of safe non-toxic treatments for many types of cancer.

Cancer Research, Immuno-Oncology, Immunotherapy, News

Could Big Data Solve Breast Cancer Research Roadblocks?

Genomic Database Going Public will Aid Cancer Research
Genomic Database Going Public will Aid Cancer Research

Could information technology be part of the solution to curing breast cancer? Researchers and healthcare specialists are about to find out as genetic profiles of thousands of cancer patients have been released to the public.

Big data meets cancer research

Results of genomic testing are normally kept confidential and stored within a patient’s file. Early this past March, Ambry Genetics made the contents of their AmbryShare database publicly available at no charge.

The database contains anonymous data obtained from testing of the company’s thousands of breast and ovarian cancer patients. Doctors, researchers and other patients can now access this information in search of genetic patterns.

“Delaying medical progress”

Amber Genetics CEO and founder Charles Dunlop, himself a stage four cancer survivor, issued a statement in conjunction with the data release. In it, he expressed shock that public and private laboratories would withhold such information at the cost of “delaying medical progress” that could end the suffering of other cancer patients.

Not everyone is optimistic about this development. Genetics professor David B. Goldstein of Columbia University told the New York Times he was unsure that this database is enough to make a difference. But one important believer is President Barack Obama, whose administration’s “Precision Medicine Initiative” is working on establishing a database containing genetic and long-term health information for one million Americans.

Genomic testing at Issels®

Genomic testing is just one of the methods we use to develop our non-toxic integrative treatments. Visit our website to view testimonials from patients with breast cancer, leukemia, melanoma and other forms of cancer which have been successfully treated at our immuno-oncology centers.

 

Alternative Cancer Treatment, Cancer Research

New Treatment Uses T-Cells to Fight Cancer at the Root

New T-Cells to Fight Cancer
New T-Cells to Fight Cancer

One of the major road blocks in cancer research has been the unchecked mutations undergone by cancer cells, creating a moving target. An international team recently made a discovery that could overcome the problem, leading to a breakthrough for integrative immunotherapy methods.

Targeting the “tree trunk”

The group of researchers found that, in addition to random mutations, cancer cells within an individual also share specific mutations that can be isolated and attacked. Dr. Sergio Quezada of University College London’s Cancer Institute, co-author of the study, likened the approach to killing a “tree trunk” rather than fighting a tangle of branches.

Creating customized treatment

Dr. Quezeda went on to explain that a customized vaccine could be developed to attack the core mutations in a particular patient. Another possibility would be discovering which T-cells produced by the immune system fight the specific mutations. Those T-cells would then be “fished” from the patient, multiplied in a lab, and re-injected into the body.

What’s in the future?

According to Dr. Quezeda, he believes these specialized treatments would be most effective against melanoma and lung cancer. Both are on the list of the 10 most common forms of cancer in the United States. Dr. Quezeda is hopeful that, in light of this study, trials will begin within five years.

Our Issels® integrative immunotherapy centers have long been in the forefront of using personalized treatment protocols. Each patient receives a specifically created program based on genetic predisposition, lifestyle, environment and other individual factors. Visit our website to read and watch testimonials from patients who have been successfully treated at the Issels® treatment centers.

Cancer Care Tips, Cancer Research, Living with Cancer

Poor Diet May Raise the Risk for Lung Cancer

Eating During Cancer Treatment
Improving Your Diet

According to the Centers for Disease Control and Prevention, smoking is the number one cause of preventable disease in the United States, and the link between smoking and cancer of the lung has been well-established for decades. Now researchers are finding that diet can also increase the risk of developing lung cancer.

Can carbohydrates lead to cancer?

Glycemic index (GI) measures how much a food’s carbohydrate content raises blood sugar. GI is used by diabetics to manage their diet, and it’s been studied as a possible factor in several types of cancer, such as colorectal, stomach and ovarian.

A research team at MD Anderson Cancer Center in Houston questioned a group of people recently diagnosed with lung cancer about their eating habits, income and other lifestyle factors. Results were compared to a control group of people without the disease.

Data shows that people who reported eating many foods with a high GI were 50 percent more likely to be in the group with lung cancer. Surprisingly, non-smokers with a high GI diet were found to be twice as likely to have the cancer as smokers with similar eating habits.

How high GI foods increase cancer risk

While doctors are not yet sure what drives the connection, they suspect it may have to do with high GI foods raising the body’s insulin production, which affects cell growth. These insulin-like growth factors (IGF) may in turn fuel the uncontrolled cell growth that leads to cancer.

Non-toxic immunotherapy treatments used at Issels® have been used successfully in patients with all types of cancer, including lung, breast and colon. Contact us for more information.

Alternative Cancer Treatment, Cancer Care Tips, Cancer Research, News

US Takes “Moonshot” Approach to a Cure for Cancer – Can It Work?

The Moonshot Approach
The Moonshot Approach

Last year, Vice President Joe Biden made news promising a “moonshot” approach toward facilitating cancer research. His announcement was inspired by his son Beau’s untimely death from brain cancer. While experts appreciate Biden’s dedication to the cause, some are warning against unrealistic expectations for a cure in the near future.

In an editorial that appeared last January in the Washington Post, cancer researcher Vinay Prasad of Oregon Health and Science University compared Biden’s vision to previous lofty promises that ultimately fizzled. Prasad went on to examine the various proposals, considering the likelihood of each to succeed.

  1. Speedier approval of cancer drugs

Prasad compares the impact of this factor to “thinking you can run a faster mile by buying a new stopwatch.” Although the FDA has already demonstrated a willingness to approve most cancer drugs, their actions have no affect whatsoever on the effectiveness of these drugs.

  1. Analysis and application of past successes

Some have suggested working backwards to study individuals with a positive response to treatment and extrapolating those findings to other patients. The problem lies in proving a direct correlation between their improvement and the drugs that were used as opposed to other unrelated factors.

  1. Immunotherapy

Therapies that boost a patient’s own immune response to cancer, such as those used at our immuno-oncology center, were cited by Biden as a promising answer. But several immunotherapy drugs have already been developed, with many more studies in progress, so that’s hardly a novel suggestion.

You can count on receiving state-of-the-art treatments at our Issels® immuno-oncology center. Visit our website for more information about our non-toxic individualized protocols.

Alternative Cancer Treatment, Cancer Research, Immuno-Oncology

BBC Reviews the “Right” Way to Fight Cancer

Stop Cancer Sign
It’s Time to Stop Cancer!

Cancer is the #2 cause of death in the United States. Untold amounts of time and money have been spent researching treatments, such as the non-toxic protocols used at our immuno-oncology center. But is the fight against cancer going in the right direction? Four experts recently spoke with BBC News about ways to improve the approach toward cancer research.

1. Relax government regulation

Dr. Vincent DeVita, instrumental in discovering the cure for Hodgkin’s disease, points to restrictive rules enforced by the Food and Drug Administration. He says it took three years for his team to develop their program, but today’s gauntlet of hurdles would stretch that time to 15 years.

2. Focus on early-stage treatments

According to MIT assistant economics professor Heidi Williams, shorter clinical trials for late-stage treatments result in more funding. Private funding is usually directed toward this research, suggesting that public funding could be allocated more for early-stage treatments studies.

3. Allocate more resources toward prevention

Political and economic considerations make cancer prevention efforts a lower priority, states Dr. Christopher Wild of WHO’s International Agency for Research on Cancer. He estimates that 40 to 50 percent of cancers could be prevented if knowledge was applied to prevention as well as treatments.

4. Educate the public

Professor Pekka Puska led a landmark experiment to reduce heart disease by educating a Finnish community about the dangers of high-risk habits. A similar campaign could be used to inform the public about the connection between cancer and individual behaviors.

Cancer treatments at our Issels® immuno-oncology center are personally tailored to focus on each patient’s particular needs. Contact us for more information.